| Therapeutic anabolic and anticatabolic benefits of natural Chinese medicines for the treatment of osteoporosis J He, X Li, Z Wang, S Bennett, K Chen, Z Xiao, J Zhan, S Chen, Y Hou, ... Frontiers in pharmacology 10, 1344, 2019 | 113 | 2019 |
| The emerging roles of hnRNPK Z Wang, H Qiu, J He, L Liu, W Xue, A Fox, J Tickner, J Xu Journal of cellular physiology 235 (3), 1995-2008, 2020 | 106 | 2020 |
| The emerging role of Hippo signaling pathway in regulating osteoclast formation W Yang, W Han, A Qin, Z Wang, J Xu, Y Qian Journal of cellular physiology 233 (6), 4606-4617, 2018 | 80 | 2018 |
| The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseases S Zhu, M Liu, S Bennett, Z Wang, KDG Pfleger, J Xu Journal of cellular physiology 236 (10), 7211-7222, 2021 | 76 | 2021 |
| Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation D Chen, Z Ye, C Wang, Q Wang, H Wang, V Kuek, Z Wang, H Qiu, J Yuan, ... Pharmacological Research 159, 104944, 2020 | 44 | 2020 |
| Cistanche deserticola polysaccharide attenuates osteoclastogenesis and bone resorption via inhibiting RANKL signaling and reactive oxygen species production D Song, Z Cao, Z Liu, J Tickner, H Qiu, C Wang, K Chen, Z Wang, S Dong, ... Journal of cellular physiology 233 (12), 9674-9684, 2018 | 43 | 2018 |
| Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis Q Wang, L Yao, K Xu, H Jin, K Chen, Z Wang, Q Liu, Z Cao, J Kenny, ... Journal of Cellular and Molecular Medicine 23 (1), 380-394, 2019 | 34 | 2019 |
| Sesamolin protects mice from ovariectomized bone loss by inhibiting osteoclastogenesis and RANKL-mediated NF-κB and MAPK signaling pathways X Yang, J Liang, Z Wang, Y Su, Y Zhan, Z Wu, J Li, X Li, R Chen, J Zhao, ... Frontiers in Pharmacology 12, 664697, 2021 | 31 | 2021 |
| Inhibitory effects of biochanin A on titanium particle‐induced osteoclast activation and inflammatory bone resorption via NF‐κB and MAPK pathways S Liao, W Feng, Y Liu, Z Wang, X Ding, F Song, X Lin, H Song, A Kc, Y Su, ... Journal of cellular physiology 236 (2), 1432-1444, 2021 | 28 | 2021 |
| Rhoifolin ameliorates titanium particle‐stimulated osteolysis and attenuates osteoclastogenesis via RANKL‐induced NF‐κB and MAPK pathways S Liao, F Song, W Feng, X Ding, J Yao, H Song, Y Liu, S Ma, Z Wang, ... Journal of cellular physiology 234 (10), 17600-17611, 2019 | 26 | 2019 |
| Vaccarin prevents titanium particle‐induced osteolysis and inhibits RANKL‐induced osteoclastogenesis by blocking NF‐κB and MAPK signaling pathways Y Liu, FM Song, ST Ma, A Moro, WY Feng, SJ Liao, XX Lin, JM Zhao, ... Journal of cellular physiology 234 (8), 13832-13842, 2019 | 26 | 2019 |
| Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3 D Song, Z Cao, J Tickner, H Qiu, C Wang, K Chen, Z Wang, C Guo, ... Archives of biochemistry and biophysics 647, 76-83, 2018 | 26 | 2018 |
| Vindoline inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice Y Zhan, J Liang, K Tian, Z Che, Z Wang, X Yang, Y Su, X Lin, F Song, ... Frontiers in Pharmacology 10, 1587, 2020 | 25 | 2020 |
| Evodiamine inhibits RANKL‐induced osteoclastogenesis and prevents ovariectomy‐induced bone loss in mice H Jin, L Yao, K Chen, Y Liu, Q Wang, Z Wang, Q Liu, Z Cao, J Kenny, ... Journal of cellular and molecular medicine 23 (1), 522-534, 2019 | 23 | 2019 |
| Cycloastragenol attenuates osteoclastogenesis and bone loss by targeting RANKL-induced nrf2/keap1/ARE, NF-κB, calcium, and NFATc1 pathways G Wang, C Ma, K Chen, Z Wang, H Qiu, D Chen, J He, C Zhang, D Guo, ... Frontiers in Pharmacology 12, 810322, 2022 | 21 | 2022 |
| Pectolinarigenin prevents bone loss in ovariectomized mice and inhibits RANKL‐induced osteoclastogenesis via blocking activation of MAPK and NFATc1 signaling Y Xiao, K Li, Z Wang, F Fu, S Shao, F Song, J Zhao, W Chen, Q Liu, J Xu Journal of Cellular Physiology 234 (8), 13959-13968, 2019 | 21 | 2019 |
| Diosmetin inhibits osteoclast formation and differentiation and prevents LPS‐induced osteolysis in mice S Shao, F Fu, Z Wang, F Song, C Li, Z Wu, J Ding, K Li, Y Xiao, Y Su, ... Journal of Cellular Physiology 234 (8), 12701-12713, 2019 | 21 | 2019 |
| Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption K Tian, Y Su, J Ding, D Wang, Y Zhan, Y Li, J Liang, X Lin, F Song, ... Life sciences 244, 117336, 2020 | 20 | 2020 |
| Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL‐induced osteoclastogenesis H Jin, Q Wang, K Chen, K Xu, H Pan, F Chu, Z Ye, Z Wang, J Tickner, ... Journal of Cellular and Molecular Medicine 23 (12), 8355-8368, 2019 | 20 | 2019 |
| Helvolic acid attenuates osteoclast formation and function via suppressing RANKL‐induced NFATc1 activation K Chen, Y Yuan, Z Wang, D Song, J Zhao, Z Cao, J Chen, Q Guo, L Chen, ... Journal of Cellular Physiology 234 (5), 6477-6488, 2019 | 19 | 2019 |
